Cartrophen Vet Inj.sc 100mg/mL 100 mg Solution is a Health Canada–registered veterinary drug (DIN 02082101) held by Biopharm Australia Pty Ltd., containing Pentosan Polysulfate Sodium. Health Canada lists its status as Marketed (status date 31 Dec 1995). Nexara Health has matched 38 registrations of Pentosan Polysulfate Sodium across 15 other regulated markets.
Health Canada registration
| DIN | 02082101 |
|---|---|
| Brand name | Cartrophen Vet Inj.sc 100mg/mL |
| Active ingredient | Pentosan Polysulfate Sodium |
| Strength | 100 mg |
| Dosage form | Solution |
| Route | Subcutaneous |
| Company | Biopharm Australia Pty Ltd. |
| Status | Marketed — 31 Dec 1995 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Pentosan Polysulfate Sodium registered in other markets
38 registrations of the same molecule in 15 national registries outside Canada (first 32 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Czech Republic | Elmiron | — | 100MG | Cps Dur | R | SUKL DLP |
| Czech Republic | Elmiron | — | 100MG | Cps Dur | R | SUKL DLP |
| Czech Republic | Elmiron | — | 100MG | Cps Dur | R | SUKL DLP |
| Denmark | Cartrophen Vet. | Maperath Herbal Ltd. | 100 mg/ml | injektionsvæske, opløsning | National | Laegemiddelstyrelsen |
| Denmark | elmiron | Bene-Arzneimittel GmbH | 100 mg | kapsler, hårde | Central | Laegemiddelstyrelsen |
| Denmark | Osteopen Vet. | Chanelle Pharmaceuticals Manufacturing Limited | 100 mg/ml | injektionsvæske, opløsning | MRP | Laegemiddelstyrelsen |
| European Union (EMA) | Elmiron | bene-Arzneimittel GmbH | Authorised | EMA centrally authorised | ||
| Hungary | Elmiron 100 mg Kemény Kapszula | Bene Arzneimittel GmbH | 90x hdpe palackban | NEAK PUPHA | ||
| Iceland | Elmiron | Parlogis - óskráð lyf | 100 mg | hylki | 0 | Lyfjastofnun lyfjaverdskra |
| Ireland | elmiron 100 mg capsules, hard | bene-Arzneimittel GmbH | Capsule, hard | Unknown | HPRA | |
| Netherlands | Elmiron 100 mg, harde capsules | Bene Arzneimittel GmbH | Capsule, hard | Uitsluitend recept | EU national register | |
| Norway | Elmiron kaps 100 mg | bene-Arzneimittel GmbH | 90 | Kapsel, hard | Aktiv oppføring | FEST (DMP) |
| Poland | Cartrophen Vet | Maperath Herbal Limited | 100 mg/ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Poland | Elmiron | bene Arzneimittel GmbH | 100 mg | Kapsułki twarde | URPL RPL | |
| Poland | Osteopen | Chanelle Pharmaceuticals Manufacturing Ltd. | 100,0 mg/ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Saudi Arabia | Hemoclar Cream 0.5gm-100gm | — | 0.5 | Inactive | SFDA | |
| South Africa | Tavan-SP 54 Injection | Sanofi Aventis South Africa (Pty) Ltd | 100 mg/ml | Inj | Discontinued | DoH SEP database |
| Taiwan | Pentosan Polysulfate Sodium | Swati Spentose Private Limited Unit I | （粉） | Registered | TFDA | |
| Turkey | Armiro 100 mg Sert Kapsul (100 Kapsul) | Argi̇s İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ | Aktif | TITCK | ||
| Turkey | Elmidam 100 mg Sert Kapsul (100 Kapsul) | Beymed İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ | Aktif | TITCK | ||
| Turkey | Elmiron 100 mg 100 Kapsul | Aymed İlaç.san.ti̇c.ltd.şti̇. | Aktif | TITCK | ||
| United Kingdom | Pentosan polysulfate sodium 100mg capsules | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Pentosan polysulfate sodium 100mg/1ml solution for injection vials | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Pentosan polysulfate sodium 50mg capsules | — | 0001 | NHS dm+d VMP | ||
| United States | Elmiron | Janssen Pharmaceuticals, Inc. | Capsule, Gelatin Coated | listed | FDA NDC | |
| United States | Pentosan Polysulfate Sodium | Swati Spentose Private Limited | Powder | FDA NDC | ||
| United States | Pentosan Polysulfate Sodium | Darmerica, LLC | Powder | FDA NDC | ||
| United States | Pentosan Polysulfate Sodium | Indena SpA | Powder | FDA NDC | ||
| United States | Pentosan Polysulfate Sodium | Aragen Life Sciences Limited | Powder | FDA NDC | ||
| United States | Pentosan Polysulfate Sodium | Medisca Inc. | Powder | FDA NDC | ||
| United States | Pentosan Polysulfate Sodium | Micro Labs Limited | Powder | FDA NDC | ||
| United States | Pentosan Polysulfate Sodium | Swati Spentose Private Limited | Powder | FDA NDC |
See every manufacturer of Pentosan Polysulfate Sodium worldwide →
Regulator price references for Pentosan Polysulfate Sodium
Published list or reimbursement prices for Pentosan Polysulfate Sodium presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Hungary | Elmiron 100 mg Kemény Kapszula | 100mg | 90x hdpe palackban | 161,399.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Iceland | Elmiron | 100mg | kassar | 81,093.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Norway | Elmiron | 100mg | 90 stk | 6,602.30 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Saudi Arabia | Hemoclar Cream 0.5gm-100gm | 6.00 SAR | public | SFDA | 2026-09-01 | ||
| South Africa | Tavan-SP 54 Injection | 100mg/1ml | 1 | 201.70 ZAR | single exit price | DoH SEP database | 2026-09-01 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Cartrophen Vet Inj.sc 100mg/mL (DIN 02082101) marketed in Canada?
Yes. Health Canada lists DIN 02082101 as Marketed as of 31 Dec 1995.
Who holds the Canadian licence for this product?
Biopharm Australia Pty Ltd. is the company of record in the Health Canada Drug Product Database.
Is Pentosan Polysulfate Sodium registered outside Canada?
Yes — Nexara Health has matched 38 registrations in 15 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02082101, status date 1995-12-31; national medicine registries: DoH SEP database, EMA centrally authorised, EU national register, FDA NDC, FEST (DMP), HPRA, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NEAK PUPHA, NHS dm+d VMP, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, Lyfjastofnun lyfjaverdskra, NEAK PUPHA, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02082101, status date 1995-12-31; national medicine registries: DoH SEP database, EMA centrally authorised, EU national register, FDA NDC, FEST (DMP), HPRA, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NEAK PUPHA, NHS dm+d VMP, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, Lyfjastofnun lyfjaverdskra, NEAK PUPHA, SFDA.
Health Canada Drug Product Database (DPD), DIN 02082101, status date 1995-12-31; national medicine registries: DoH SEP database, EMA centrally authorised, EU national register, FDA NDC, FEST (DMP), HPRA, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NEAK PUPHA, NHS dm+d VMP, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, Lyfjastofnun lyfjaverdskra, NEAK PUPHA, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.